XML 204 R177.htm IDEA: XBRL DOCUMENT v3.20.4
Parent Company Only Condensed Financial Information - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Adjustments to reconcile net income to net cash used for operating activities:      
Gains on investment securities, net $ (420,752) $ (134,670) $ (88,094)
Gains on derivatives, net (237,428) (138,078) (89,142)
Amortization of share-based compensation 83,986 66,815 45,675
Other, net (287,905) (74,240) (54,039)
Net cash provided by operating activities 1,445,487 1,164,129 933,562
Cash flows from investing activities:      
Net decrease (increase) in loans (11,926,436) (4,773,775) (5,175,409)
Business acquisitions 26,700 102,328 0
Net cash used for investing activities (31,205,721) (9,371,882) (4,800,375)
Cash flows from financing activities:      
Principal payments of long-term debt 0 (358,395) 0
Proceeds from issuance of common stock, ESPP and ESOP 31,146 24,818 18,387
Net proceeds from the issuance of preferred stock 0 340,138 0
Payment of preferred stock dividends (17,151) 0 0
Common stock repurchase (60,020) (352,511) (147,123)
Net cash provided by financing activities 40,653,214 11,417,997 4,515,277
Net increase in cash and cash equivalents 10,892,980 3,210,244 648,464
Cash and cash equivalents at beginning of period 6,781,783 3,571,539 2,923,075
Cash and cash equivalents at end of period 17,674,763 6,781,783 3,571,539
Parent Company      
Condensed Cash Flow Statements, Captions [Line Items]      
Net income before preferred stock dividend 1,208,368 1,136,856 973,840
Adjustments to reconcile net income to net cash used for operating activities:      
Gains on equity warrant assets, net (30,018) 0 0
Gains on investment securities, net (157,594) (45,345) (13,546)
Gains on derivatives, net (226,942) (138,078) (89,142)
Distributions of earnings from investment securities 65,237 49,776 47,596
Net income of subsidiaries (211,213) (775,867) (154,987)
Cash dividends from bank subsidiary 50,000 733,000 140,000
Amortization of share-based compensation 83,986 66,815 45,675
Decrease in other assets 17,189 27,205 51,169
Increase in other liabilities 98,209 21,391 21,619
Other, net 13,206 8,084 (31,024)
Net cash provided by operating activities 74,486 765,715 187,334
Cash flows from investing activities:      
Net decrease in investment securities from purchases, sales and maturities 122,823 128,635 73,742
Net decrease (increase) in loans 14,563 (15,245) 0
Net cash used for investing activities (653,673) (171,888) 37,127
Cash flows from financing activities:      
Principal payments of long-term debt 0 (358,395) 0
Proceeds from issuance of 3.125% Senior Notes 495,024 0 0
Proceeds from issuance of common stock, ESPP and ESOP 31,146 24,818 18,387
Net proceeds from the issuance of preferred stock 0 340,138 0
Payment of preferred stock dividends   0 0
Common stock repurchase (60,020) (352,511) (147,123)
Net cash provided by financing activities 448,999 (345,950) (128,736)
Net increase in cash and cash equivalents (130,188) 247,877 95,725
Cash and cash equivalents at beginning of period 800,926 553,049 457,324
Cash and cash equivalents at end of period 670,738 800,926 553,049
Bank Subsidiary | Parent Company      
Adjustments to reconcile net income to net cash used for operating activities:      
Net income of subsidiaries (826,243) (1,036,618) (933,641)
Cash flows from investing activities:      
Increase (decrease) in investment in subsidiaries (68,630) (42,952) (31,292)
Capital Infusion In Bank Subsidiary (700,000) 0 0
Nonbank Subsidiaries | Parent Company      
Adjustments to reconcile net income to net cash used for operating activities:      
Net income of subsidiaries (220,912) (57,371) (25,212)
Cash flows from investing activities:      
Increase (decrease) in investment in subsidiaries 4,271 23,275 (5,323)
Business acquisitions $ 26,700 $ 265,601 $ 0